how to find the right treatment at the right time
play

HOW TO FIND THE RIGHT TREATMENT, AT THE RIGHT TIME: MICROFLUIDICS - PowerPoint PPT Presentation

HOW TO FIND THE RIGHT TREATMENT, AT THE RIGHT TIME: MICROFLUIDICS CAN HELP! Prof. Gabriele Dubini | Politecnico di Milano MASTERCLASS SERIES 2020 VIRTUAL EXPERIENCE DRUG SCREENING Drug screening is the process by which potential drugs are


  1. HOW TO FIND THE RIGHT TREATMENT, AT THE RIGHT TIME: MICROFLUIDICS CAN HELP! Prof. Gabriele Dubini | Politecnico di Milano MASTERCLASS SERIES 2020 VIRTUAL EXPERIENCE

  2. DRUG SCREENING Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials Drug n°1 Drug n°2 … Drug n°50 Tumour Cells from In vitro tests !!! Cancer patients biopsy biopsy on EFFICACY 2 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  3. DRUG SCREENING Single drug Drug n°1 Drug n°2 … Drug n°50 In vitro tests on EFFICACY 3 ‹N› MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  4. DRUG SCREENING X 10… X 100… X 1000… Single drug Comb. of 2 drugs Multiple combinations Drug n°1 Diff. timing of Drug n°2 administration … Drug n°50 Dosages … In vitro tests on EFFICACY 4 ‹N› MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  5. DRUG SCREENING X 10… Common laboratory practices X 100… !!! X 1000… They are Time consuming 5 ‹N› MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  6. DRUG SCREENING X 10… Common laboratory practices X 100… Automation for high-throughput management X 1000… Cannot manage efficiently jelly components such as biological matrices !!! Cannot directly manage any flow !!! 6 ‹N› MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  7. DRUG SCREENING To screen the efficacy of the treatment and build up -PATIENT SPECIFIC- models or predictions to overcome current limitations WHAT DO WE NEED? 7 ‹N› MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  8. DRUG SCREENING What do we need? A patient-specific tumor microenvironment Biological/genetic materials DRUG secreted by cells Flow OXYGEN FEEDING WASTE Multiple combinations biological matrices Diff. timing of !!! administration flow Dosages !!! 8 ‹N› MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  9. DRUG SCREENING Common laboratory practices High-throughput robots Microfluidics can help! 9 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  10. DRUG SCREENING Common laboratory practices High-throughput robots Microfluidics can help! HOW? 10 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  11. DRUG SCREENING Common laboratory practices High-throughput robots HOW? Microfluidics can help! 11 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  12. DRUG SCREENING Common laboratory practices High-throughput robots HOW? Microfluidics can help! • Miniaturization • Reduction of experiment time • Reduction of overall costs • Improvement of experiment precision • Reduction of sample and reagent consumption 12 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  13. MICROFLUIDICS Microfluidics is the science of fluids manipulation at the micron ( µm ) scale m Red blood cells cm mm Hair 8 µm µ m 13 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  14. MICROFLUIDICS Microfluidics is the science of fluids manipulation at the micron ( µm ) scale Microfluidics can be found in nature WHAT IS BEHIND? 14 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  15. MICROFLUIDICS Microfluidics is the science of fluids manipulation at the micron ( µm ) scale WHAT IS BEHIND? Surface tension Capillarity 15 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  16. MICROFLUIDICS APPLICATIONS Glycaemic Lab-on-chips tests Drug delivery Point of care systems diagnostics EVERYDAY (e.g. insulin) (e.g. COVID19) LIFE & LAB TOOLS Analytical Pregnancy devices tests 16 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  17. ACCELERATOR PROJECT ACCELERATOR AWARD A26819 Objectives : study of drug-resistance mechanism and identification of the best therapeutic treatments for drug-resistant patients using a novel microfluidic platform Cells from tumour biopsy Biological matrix 17 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  18. MICROFLUIDIC PLATFORM DROPS FOR DRUG SCREENING Matrigel drop FEEDING Organoid OXYGEN Well DRUG Medium/Drug WASTE Biological/genetic materials 18 18 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  19. MICROFLUIDIC PLATFORM - DROPS FOR DRUG SCREENING DROPS GENERATION in MICROCHANNELS Matrigel drop 19 19 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  20. MICROFLUIDIC PLATFORM - DROPS FOR DRUG SCREENING Multicomponent FLOW around the drop DROPS GENERATION in MICROCHANNELS FEEDING OXYGEN DRUG WASTE Matrigel drop Biological/genetic materials 20 20 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  21. MICROFLUIDIC PLATFORM DROPS FOR DRUG SCREENING 2 cm 21 21 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  22. RESEARCH GROUP ACCELERATOR AWARD A26819 Nicola Valeri Gabriele Dubini Giovanni Tonon Elena Bianchi Paola De Stefano Oronzina Botrugno Assistant Professor PhD Candidate Post Doc 22 22 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  23. ACKNOWLEDGEMENTS We thank DiCE for participating in the project and bringing the patient’s voice into research 23 23 MASTERCLASS SERIES – 2020 VIRTUAL EXPERIENCE – PROF. GABRIELE DUBINI

  24. THANK YOU

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend